Zealand Pharma AS (ZLDPF)
135.65
+2.24
(+1.68%)
USD |
OTCM |
Sep 20, 16:00
Zealand Pharma Gross Profit Margin (Quarterly): 72.20% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 72.20% |
| March 31, 2024 | 69.53% |
| December 31, 2023 | 39.69% |
| September 30, 2023 | 98.25% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | 68.05% |
| March 31, 2021 | |
| December 31, 2020 | 36.40% |
| September 30, 2020 | 39.37% |
| June 30, 2020 | 87.32% |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | 97.67% |
| June 30, 2019 | 99.08% |
| March 31, 2019 | |
| December 31, 2018 | -1.25K% |
| September 30, 2018 | |
| June 30, 2018 | 86.50% |
| Date | Value |
|---|---|
| March 31, 2018 | 86.49% |
| December 31, 2017 | 86.50% |
| September 30, 2017 | 96.77% |
| June 30, 2017 | 88.75% |
| March 31, 2017 | 86.50% |
| December 31, 2016 | 86.50% |
| September 30, 2016 | 86.54% |
| June 30, 2016 | 89.23% |
| March 31, 2016 | 86.53% |
| December 31, 2015 | 88.31% |
| September 30, 2015 | 87.18% |
| June 30, 2015 | 86.50% |
| March 31, 2015 | 86.53% |
| December 31, 2014 | 85.53% |
| September 30, 2014 | 98.61% |
| June 30, 2014 | 86.47% |
| March 31, 2014 | 86.50% |
| December 31, 2013 | 86.87% |
| September 30, 2013 | 86.67% |
| June 30, 2013 | 86.48% |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | 99.56% |
| March 31, 2012 | 87.30% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
36.40%
Minimum
Dec 2020
98.25%
Maximum
Sep 2023
67.61%
Average
69.53%
Median
Mar 2024
Gross Profit Margin (Quarterly) Benchmarks
| Novo Nordisk AS | 84.90% |
| Eli Lilly and Co | 80.80% |
| Altimmune Inc | -- |
| Genmab AS | 96.48% |
| Viking Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.55% |
| Return on Assets | -17.88% |
| Return on Invested Capital | -19.92% |
| Profit Margin (Quarterly) | -857.7% |
| Operating Margin (Quarterly) | -784.3% |
| Return on Net Operating Assets | -192.7% |